Automated Closed-Loop Versus Restrictive Fluid Therapy in Abdominal Surgery

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Abdominal Laparoscopic and/or Robotic Surgery
Interventions
DEVICE

Closed-Loop GDFT

Patients receive fluids in the form of 100ml boluses of crystalloid (Plasmalyte) over 6 minutes via an automated closed-loop goal-directed fluid therapy (GDFT) system guided by non-invasive flow monitoring (Clearsight system). Additional boluses of colloid or crystalloid can be administered under the attending anesthesiologist's discretion (e.g. to compensate blood loss) .

OTHER

Restrictive Fluid Therapy

Patients receive fluids (Plasmalyte) via a restrictive approach with a baseline of of 4ml/kg/h. Additional boluses of colloid or crystalloid can be administered under the attending anesthesiologist's discretion (e.g. to compensate blood loss) .

Trial Locations (1)

1070

Erasme University Hospital, Brussels

All Listed Sponsors
lead

Erasme University Hospital

OTHER

NCT03039946 - Automated Closed-Loop Versus Restrictive Fluid Therapy in Abdominal Surgery | Biotech Hunter | Biotech Hunter